Long-term safety and durable efficacy of esketamine in TRD and ESCAPE-TRD

JANSSEN SATELLIT SYMPOSIUM-1 - SPRAVATO Nasal Spray (Esketamine) in Treatment Resistant... (EN)

Upjohn Institute Economic Outlook: Are we headed to a recession?

Esketamine nasal spray: long term safety data [Prof Carla Canuso]

E161 - Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Real-World ...

Circular AI Deals Fuel Bubble Debate | Bloomberg Tech: Asia 11/28/25

#1 Best Meal to UNCLOG Your Arteries (Backed by Science)

Egzekucje w Norymberdze - incydenty, ostatnie mowy i chwila ciszy

Kupili nowy dom. Niebywałe, co zastali po otwarciu drzwi

Korea Policy Forum: Trade and Immigration Policy in US-ROK Relations in 2025

Grand Rounds: Novel Therapeutics in Depression: Ketamine, Esketamine, and Psychedelics

State of the School

Guest Lecture Series: Professor Sir Richard Peto - Tobacco deaths: the past 75 years and the next 75

Кетамин как средство лечения депрессии?

Опыт лечения справато (эскетамином) | Неделя 1 | Хорошие люди #справато #диссоциативноерасстройство

Prucalopride (5HT4a agonist) plus ketamine: additive effects on stress

Ketamine vs. ECT: implications for clinical practice, policy and future research

5 Things You Need to Know about Intranasal Esketamine

The Impact of FDA Approval for Esketamine as Monotherapy in Treatment-Resistant Depression

Are countries maximizing policy space to grant compulsory licenses to improve access to medicines?

Встречайте Бенедикта Камбербэтча в «Новогоднем наступлении» | World of Tanks